Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy vs Concurrent Chemoradiotherapy in EBV DNA Responding NPC
NCT05674305Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Fudan University. Started Jan 2022; status: recruiting.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05674305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674305.